These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 37775725)
21. [Expression and clinical significance of the thyroid transcription factor 1 in Xuanwei lung adenocarcinoma]. Zu Y; Wang X; Liu X; Chen Y; Li C; Shang X; Xie Y; Zhao H; Wang J Zhongguo Fei Ai Za Zhi; 2013 Mar; 16(3):131-7. PubMed ID: 23514941 [TBL] [Abstract][Full Text] [Related]
22. SMARCA4 (BRG1) and SMARCB1 (INI1) expression in TTF-1 negative neuroendocrine carcinomas including merkel cell carcinoma. Gandhi JS; Alnoor F; Sadiq Q; Solares J; Gradowski JF Pathol Res Pract; 2021 Mar; 219():153341. PubMed ID: 33581550 [TBL] [Abstract][Full Text] [Related]
23. Association of thyroid transcription factor-1 with the efficacy of immune-checkpoint inhibitors in patients with advanced lung adenocarcinoma. Nakahama K; Kaneda H; Osawa M; Izumi M; Yoshimoto N; Sugimoto A; Nagamine H; Ogawa K; Matsumoto Y; Sawa K; Tani Y; Mitsuoka S; Watanabe T; Asai K; Kawaguchi T Thorac Cancer; 2022 Aug; 13(16):2309-2317. PubMed ID: 35808895 [TBL] [Abstract][Full Text] [Related]
24. Transcription start site-level expression of thyroid transcription factor 1 isoforms in lung adenocarcinoma and its clinicopathological significance. Sano K; Hayashi T; Suehara Y; Hosoya M; Takamochi K; Kohsaka S; Kishikawa S; Kishi M; Saito S; Takahashi F; Kaneko K; Suzuki K; Yao T; Ishijima M; Saito T J Pathol Clin Res; 2021 Jul; 7(4):361-374. PubMed ID: 34014042 [TBL] [Abstract][Full Text] [Related]
25. Reciprocal expression of trefoil factor-1 and thyroid transcription factor-1 in lung adenocarcinomas. Matsubara D; Yoshimoto T; Soda M; Amano Y; Kihara A; Funaki T; Ito T; Sakuma Y; Shibano T; Endo S; Hagiwara K; Ishikawa S; Fukayama M; Murakami Y; Mano H; Niki T Cancer Sci; 2020 Jun; 111(6):2183-2195. PubMed ID: 32237253 [TBL] [Abstract][Full Text] [Related]
26. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study. Tan D; Li Q; Deeb G; Ramnath N; Slocum HK; Brooks J; Cheney R; Wiseman S; Anderson T; Loewen G Hum Pathol; 2003 Jun; 34(6):597-604. PubMed ID: 12827614 [TBL] [Abstract][Full Text] [Related]
27. Molecular genetic alterations in thyroid transcription factor 1-negative lung adenocarcinoma in cytology specimens: A subset with aggressive behavior and a poor prognosis. Rodriguez EF; VandenBussche CJ; Chowsilpa S; Maleki Z Cancer Cytopathol; 2018 Oct; 126(10):853-859. PubMed ID: 30199148 [TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. Saad RS; Liu YL; Han H; Landreneau RJ; Silverman JF Hum Pathol; 2004 Jan; 35(1):3-7. PubMed ID: 14745718 [TBL] [Abstract][Full Text] [Related]
30. Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung. Hanley KZ; Dureau ZJ; Cohen C; Shin DM; Owonikoko TK; Sica GL Cancer Cytopathol; 2018 Apr; 126(4):236-242. PubMed ID: 29316326 [TBL] [Abstract][Full Text] [Related]
31. Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment. Chung KP; Huang YT; Chang YL; Yu CJ; Yang CH; Chang YC; Shih JY; Yang PC Chest; 2012 Feb; 141(2):420-428. PubMed ID: 21799026 [TBL] [Abstract][Full Text] [Related]
32. Rapid Immunohistochemistry With Thyroid Transcription Factor-1 for Pulmonary Adenocarcinoma. Konno H; Saito H; Nanjo H; Hiroshima Y; Kurihara N; Fujishima S; Atari M; Sato Y; Motoyama S; Nakamura R; Akagami Y; Minamiya Y Ann Thorac Surg; 2017 Aug; 104(2):471-476. PubMed ID: 28527968 [TBL] [Abstract][Full Text] [Related]
33. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Ordóñez NG Am J Surg Pathol; 2000 Sep; 24(9):1217-23. PubMed ID: 10976695 [TBL] [Abstract][Full Text] [Related]
34. Clinicopathological characteristics of thyroid transcription factor 1-negative small cell lung cancers. Iida Y; Masuda S; Nakanishi Y; Shimizu T; Nishimaki H; Takahashi M; Hikichi M; Maruoka S; Gon Y; Takahashi N; Hashimoto S Hum Pathol; 2018 Sep; 79():127-134. PubMed ID: 29787820 [TBL] [Abstract][Full Text] [Related]
35. High-grade fetal adenocarcinoma of the lung is a tumour with a fetal phenotype that shows diverse differentiation, including high-grade neuroendocrine carcinoma: a clinicopathological, immunohistochemical and mutational study of 20 cases. Suzuki M; Yazawa T; Ota S; Morimoto J; Yoshino I; Yamanaka S; Inayama Y; Kawabata Y; Shimizu Y; Komatsu M; Notohara K; Koda K; Nakatani Y Histopathology; 2015 Dec; 67(6):806-16. PubMed ID: 25851923 [TBL] [Abstract][Full Text] [Related]
36. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin. Compérat E; Zhang F; Perrotin C; Molina T; Magdeleinat P; Marmey B; Régnard JF; Audouin J; Camilleri-Broët S Mod Pathol; 2005 Oct; 18(10):1371-6. PubMed ID: 15861215 [TBL] [Abstract][Full Text] [Related]
37. The role of thyroid transcription factor-1 in differentiating lung adenocarcinomas from non-pulmonary adenocarcinoma effusions. Khidir LS; Abdelwadoud ME; Abdelmola A; Babiker NE; Elemam IB; Elmahi OM; Alharthi NS; Waggiallah HA J Med Life; 2023 Jun; 16(6):932-936. PubMed ID: 37675165 [TBL] [Abstract][Full Text] [Related]
38. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Pelosi G; Fraggetta F; Pasini F; Maisonneuve P; Sonzogni A; Iannucci A; Terzi A; Bresaola E; Valduga F; Lupo C; Viale G Am J Surg Pathol; 2001 Mar; 25(3):363-72. PubMed ID: 11224607 [TBL] [Abstract][Full Text] [Related]
39. Prognostic value of mutant p53, Ki-67, and TTF-1 and their correlation with EGFR mutation in patients with non-small cell lung cancer. Zhu WY; Hu XF; Fang KX; Kong QQ; Cui R; Li HF; He JY; Zhang YK; Le HB Histol Histopathol; 2019 Nov; 34(11):1269-1278. PubMed ID: 31062864 [TBL] [Abstract][Full Text] [Related]
40. [Thyroid transcription factor-1 level is associated with epidermal growth factor receptor mutation status in patients with advanced lung adenocarcinoma]. Niu Y; Wang H; Zhang G; Ma J; Wei B; Ma Z Zhonghua Jie He He Hu Xi Za Zhi; 2014 Dec; 37(12):919-23. PubMed ID: 25609130 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]